What is an Addiction Psychiatry SOAP Note Template and Why is it Required in Substance Use Documentation?

An Addiction Psychiatry SOAP Note Template is a structured clinical document used to record evaluation and treatment of substance use disorders, covering medication-assisted treatment, withdrawal management, relapse evaluation, and co-occurring psychiatric symptoms in a standardized SOAP format. It organizes substance use history, craving and withdrawal trends, toxicology results, and MAT prescribing details into a consistent structure built for the layered clinical and regulatory demands of addiction psychiatry.

Addiction psychiatry documentation carries a weight that general psychiatry notes don't, because controlled substance prescribing for MAT requires a defensible clinical rationale documented at every visit, and diversion risk, adherence, and toxicology results all have to be tracked consistently to justify continued treatment. A generic psychiatric template has no place to document a structured substance use timeline, a withdrawal risk assessment, or MAT-specific prescribing rationale. A dedicated template prompts the clinician to document these elements together, alongside the co-occurring psychiatric symptoms that are extremely common in this population.

Because relapse risk and treatment response both depend on catching subtle changes early, structured documentation also makes it possible to track cravings, withdrawal symptoms, and toxicology trends across visits in a way that supports both clinical decision-making and regulatory review. That consistency is what protects both the patient's treatment continuity and the prescriber's documentation if MAT prescribing is ever questioned.

Why Do Generic Templates Fail

Addiction Psychiatry SOAP Note Template cases involve:

• Documenting a detailed substance use history including substances, patterns, and prior treatment attempts.
• Assessing withdrawal risk and current withdrawal symptoms using a structured, repeatable approach.
• Recording MAT prescribing details with a documented clinical rationale at every visit.
• Tracking toxicology results and diversion risk indicators consistently over time.
• Screening for co-occurring psychiatric symptoms that commonly accompany substance use disorders.

Generic addiction templates fail because they:

• Contain no structured field for a detailed substance use history and treatment attempt timeline.
• Provide no withdrawal risk assessment structure, missing a clinically urgent piece of information.
• Offer no dedicated MAT prescribing rationale section, leaving controlled substance decisions undocumented.
• Treat toxicology and diversion risk tracking as an afterthought rather than a routine part of every visit.
• Overlook co-occurring psychiatric symptoms, missing conditions that commonly complicate substance use treatment.

When Is Addiction Psychiatry SOAP Note Template Used

• MAT induction visits.
• MAT maintenance and dose adjustment visits.
• Relapse evaluation.
• Withdrawal management visits.
• Co-occurring psychiatric symptom evaluation.
• Toxicology result follow-up.
• Diversion concern evaluation.
• Post-detoxification follow-up.
• Court-mandated or employer-mandated evaluation.
• Transition of care between levels of addiction treatment.

Who Uses Addiction Psychiatry SOAP Note Template

• Addiction psychiatrists.
• MAT prescribers.
• Psychiatric nurse practitioners specializing in addiction medicine.
• Addiction medicine physicians.
• Substance use counselors supporting documentation.
• Detoxification unit providers.
• Residential treatment program psychiatric staff.
• Dual-diagnosis treatment teams.
• Correctional psychiatry providers.
• Telehealth addiction medicine providers.

Regulatory and Billing Relevance

• Supports E/M coding through:
  • Detailed history (HPI, ROS, PMH)
  • Comprehensive examination
  • Medical decision-making complexity
• Essential for medico-legal documentation, especially in:
  • Controlled substance prescribing audits for MAT
  • Diversion and misuse investigation documentation
  • Relapse and overdose event review
• Ensures compliance with documentation standards for diagnostic justification.

Addiction Psychiatry Structure: What to Include in Each Section

The following structure below reflects how Addiction Psychiatry SOAP Note Template evaluations are typically documented in practice.

• Patient Information: Name, DOB, age/sex, MRN or patient ID, date of service, provider, credentials, visit type, care setting, referring provider, counselor/therapist if applicable.
• Chief Complaint: MAT induction, MAT maintenance, relapse, withdrawal symptoms, co-occurring psychiatric symptoms, toxicology follow-up, diversion concern, or transition of care.
• Subjective: Reason for evaluation, substance use history, current use pattern, prior treatment attempts, withdrawal symptoms, craving intensity, MAT adherence, co-occurring psychiatric symptoms, psychosocial stressors, legal/employment involvement, prior evaluation and treatment, pertinent negatives.
• Addiction Psychiatry Review of Systems: Cravings, withdrawal symptoms, or relapse triggers, mood symptoms, anxiety, or trauma symptoms, sleep disturbance, appetite change, or fatigue, pain symptoms or chronic pain concerns, cognitive or memory concerns, medical complications of substance use, medication side effects, adherence or diversion concerns.
• Vitals: Temperature, blood pressure, heart rate, respiratory rate, oxygen saturation, weight, pain score, withdrawal scale score if used.
• Objective / Mental Status Examination: General appearance, behavior, speech, mood, affect, thought process, thought content, perception, cognition, insight, judgment, impulse control, signs of intoxication or withdrawal.
• Standardized Screening / Assessment Tools: COWS or CIWA-Ar, PHQ-9, GAD-7, C-SSRS, ASAM criteria dimensions, urine drug screen or toxicology, other scales, including score, severity range, comparison to prior scores, and clinical interpretation.
• Risk Assessment: Overdose risk, withdrawal severity risk, suicidal ideation, plan, intent, means, past attempts, protective factors, relapse risk factors, diversion or misuse risk, co-occurring medical risk, overall risk level, clinical rationale, safety plan or naloxone provision or higher level of care recommendation.
• Laboratory and Diagnostic Results: Urine drug screen or toxicology results, liver function and infectious disease screening, pregnancy testing if applicable, prescription monitoring program review, prior records reviewed.
• Assessment: Primary substance use diagnosis, severity, co-occurring psychiatric diagnoses, current withdrawal or intoxication status, MAT adequacy and adherence, toxicology and PMP findings, diversion or misuse concerns, psychosocial stressors, risk formulation, need for level of care change or referral.
• Plan: MAT prescribing plan with dose and rationale, withdrawal management plan, psychiatric medication plan, counseling/therapy referral, toxicology monitoring plan, naloxone provision, level of care recommendation, care coordination with counselor or program, patient education.
• Follow-Up: Follow-up timeframe, MAT dose reassessment, toxicology recheck, withdrawal/craving reassessment, co-occurring symptom review, PMP recheck, counseling engagement follow-up, level of care reassessment.
• Time Documentation: Total time spent, medication management time, counseling time, care coordination time, records review time.
• Billing Considerations: E/M level, MAT induction/maintenance codes, psychotherapy codes, basis for billing, ICD-10 diagnosis codes.
• Signature: Provider name, credentials, specialty, DEA/X-waiver status if applicable, date, time.

How to write Addiction Psychiatry SOAP Note Template with examples?

The template above shows the blank structure. Below is the same Addiction Psychiatry SOAP Note filled out with a realistic example, so you can see exactly how each section reads once it's completed with patient information, clinical findings, and a documented treatment plan.

Customizing Your Addiction Psychiatry SOAP Note Template to Match Your Documentation Style

The template gives you the structure. When you start using it with Marvix AI, the documentation itself adapts to how you write.

Marvix AI uses neural style transfer to learn from your existing notes, so you have custom made templates for all your workflows. It picks up your tone, your phrasing, and structure, then carries that into every note it generates.

If your notes are concise and point-wise, the output stays that way. If you write in a more narrative flow, it follows that instead. The note reads like something you wrote, not something you cleaned up.

This carries across clinical notes, after visit summaries, referral letters, IME reports and every other kind of documentation. And when you need a template for a new document type, Marvix AI builds it from your existing notes rather than starting from scratch.

Common Documentation Mistakes in Addiction Psychiatry Notes (and How to Avoid Them)

• Not documenting a structured withdrawal assessment
  Relying on general impression rather than a standardized scale like COWS or CIWA-Ar to assess withdrawal severity leaves the clinical decision-making undocumented.
  How to improve: Use a standardized withdrawal scale and document the specific score at every visit where withdrawal is a concern.
  ‍
• Prescribing MAT without a documented rationale
  Continuing or adjusting a MAT dose without recording the specific clinical reasoning, such as craving control or withdrawal suppression, leaves the prescribing decision unsupported if reviewed later.
  How to improve: Document the specific clinical rationale for every MAT dose decision, referencing symptoms, cravings, and toxicology findings.
  ‍
• Not reviewing toxicology results consistently
  Skipping a review of recent urine drug screen or prescription monitoring program results at routine visits can miss early signs of relapse or diversion.
  How to improve: Review and document toxicology and PMP findings at every visit, not only when a specific concern is raised.
  ‍
• Screening only for substance use and missing co-occurring symptoms
  Focusing exclusively on substance use without screening for depression, anxiety, or trauma symptoms misses conditions that commonly complicate treatment and relapse risk.
  How to improve: Screen for co-occurring psychiatric symptoms explicitly at every visit, using standardized tools when appropriate.
  ‍
• Not documenting naloxone provision or overdose risk counseling
  Omitting documentation of naloxone provision and overdose risk counseling in a high-risk patient leaves a gap in the harm reduction record.
  How to improve: Document naloxone provision and overdose risk counseling explicitly whenever overdose risk is present.
  ‍

Addiction Psychiatry Comparison: Generic Templates vs AI Scribes vs Marvix AI

An addiction psychiatry SOAP note template gives clinicians a consistent framework for documenting substance use treatment, but withdrawal scoring, MAT prescribing rationale, and toxicology trend tracking still have to be managed manually. Most AI scribes are built for general visit transcription and are not designed to structure MAT-specific prescribing documentation or standardized withdrawal scales. Marvix AI combines specialty-aware documentation with historical patient information, provider-specific writing styles, and structured workflows to produce complete addiction psychiatry notes that support both clinical continuity and controlled substance prescribing defensibility.